Ultralife Corp. (NASDAQ: ULBI) reported Q3 EPS of $0.02, $0.16 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $35.7 million versus the consensus estimate of $43 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.